1.64
price up icon6.49%   0.10
after-market Handel nachbörslich: 1.64
loading
Schlusskurs vom Vortag:
$1.54
Offen:
$1.55
24-Stunden-Volumen:
7.75M
Relative Volume:
0.88
Marktkapitalisierung:
$492.14M
Einnahmen:
$188.87M
Nettoeinkommen (Verlust:
$-400.38M
KGV:
-1.0933
EPS:
-1.5
Netto-Cashflow:
$-260.90M
1W Leistung:
+13.10%
1M Leistung:
+27.13%
6M Leistung:
+1.86%
1J Leistung:
-23.19%
1-Tages-Spanne:
Value
$1.535
$1.69
1-Wochen-Bereich:
Value
$1.45
$1.71
52-Wochen-Spanne:
Value
$0.8511
$2.72

Pacific Biosciences Of California Inc Stock (PACB) Company Profile

Name
Firmenname
Pacific Biosciences Of California Inc
Name
Telefon
650-521-8000
Name
Adresse
1305 O'BRIEN DRIVE, MENLO PARK, CA
Name
Mitarbeiter
575
Name
Twitter
@pacbio
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
PACB's Discussions on Twitter

Vergleichen Sie PACB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
PACB
Pacific Biosciences Of California Inc
1.64 462.13M 188.87M -400.38M -260.90M -1.50
Medical Devices icon
ABT
Abbott Laboratories
126.35 220.16B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
105.84 157.03B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
SYK
Stryker Corp
400.69 154.21B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
91.97 119.08B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
78.49 46.93B 5.69B 4.15B 623.10M 6.95

Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-11 Herabstufung UBS Buy → Neutral
2024-06-03 Fortgesetzt Jefferies Buy
2024-04-22 Herabstufung JP Morgan Overweight → Neutral
2024-04-18 Herabstufung Goldman Buy → Neutral
2023-12-14 Eingeleitet Guggenheim Neutral
2023-12-14 Eingeleitet Stephens Overweight
2023-12-13 Eingeleitet Wolfe Research Peer Perform
2023-11-17 Hochstufung UBS Neutral → Buy
2023-10-31 Hochstufung Cantor Fitzgerald Neutral → Overweight
2023-09-28 Eingeleitet Bernstein Outperform
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-06-30 Eingeleitet Goldman Buy
2023-05-10 Eingeleitet Barclays Equal Weight
2023-03-31 Hochstufung TD Cowen Market Perform → Outperform
2023-02-02 Eingeleitet UBS Neutral
2023-01-20 Herabstufung Cantor Fitzgerald Overweight → Neutral
2023-01-05 Eingeleitet Scotiabank Sector Outperform
2022-01-21 Fortgesetzt Cantor Fitzgerald Overweight
2022-01-06 Fortgesetzt Piper Sandler Neutral
2021-10-15 Fortgesetzt Cowen Market Perform
2021-09-27 Eingeleitet Canaccord Genuity Buy
2021-02-11 Hochstufung Piper Sandler Neutral → Overweight
2020-11-03 Herabstufung Piper Sandler Overweight → Neutral
2020-10-02 Hochstufung JP Morgan Neutral → Overweight
2020-09-09 Eingeleitet Morgan Stanley Equal-Weight
2020-06-02 Fortgesetzt Cantor Fitzgerald Overweight
2020-03-09 Fortgesetzt Cantor Fitzgerald Overweight
2019-10-15 Hochstufung Piper Jaffray Neutral → Overweight
2019-04-02 Herabstufung Stephens Overweight → Equal-Weight
2018-10-19 Eingeleitet Cowen Outperform
2017-11-03 Herabstufung First Analysis Sec Overweight → Equal-Weight
2017-09-28 Herabstufung CL King Buy → Neutral
2016-11-03 Bestätigt Cantor Fitzgerald Buy
2016-06-27 Eingeleitet CL King Buy
2016-04-15 Eingeleitet First Analysis Sec Overweight
2016-02-04 Herabstufung Piper Jaffray Overweight → Neutral
2016-01-04 Bestätigt Cantor Fitzgerald Buy
2015-10-23 Hochstufung Piper Jaffray Neutral → Overweight
2015-08-27 Eingeleitet Cantor Fitzgerald Buy
2015-02-04 Bestätigt Maxim Group Buy
2013-09-26 Bestätigt Maxim Group Buy
2013-01-14 Bestätigt Maxim Group Buy
Alle ansehen

Pacific Biosciences Of California Inc Aktie (PACB) Neueste Nachrichten

pulisher
09:28 AM

Is it the right time to buy Pacific Biosciences of California Inc. stockBuild a winning investment portfolio - jammulinksnews.com

09:28 AM
pulisher
07:55 AM

What is Pacific Biosciences of California Inc. company’s growth strategyMaximize your portfolio’s growth potential - jammulinksnews.com

07:55 AM
pulisher
06:49 AM

Is Pacific Biosciences of California Inc. a growth stock or a value stockCapitalize on momentum-driven investment opportunities - jammulinksnews.com

06:49 AM
pulisher
03:35 AM

How does Pacific Biosciences of California Inc. generate profit in a changing economyCapitalize on proven trading setups - jammulinksnews.com

03:35 AM
pulisher
Jul 27, 2025

Why is Pacific Biosciences of California Inc. stock attracting strong analyst attentionBuild wealth steadily with smart stock selection - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How strong is Pacific Biosciences of California Inc. company’s balance sheetInvest smarter with expert stock recommendations - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are analysts’ price targets for Pacific Biosciences of California Inc. in the next 12 monthsRealize exceptional returns through smart trading - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Here's Why You Should Add PacBio Stock to Your Portfolio Now - MSN

Jul 27, 2025
pulisher
Jul 25, 2025

What makes Pacific Biosciences of California Inc. stock attractive to long term investorsExplosive capital appreciation - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Pacific Biosciences shares rise 1.30% premarket after announcing significant advancement in genomic sequencing. - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Pacific Biosciences of California Inc. Stock Analysis and ForecastExplosive returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

PacBio (PACB) Technology Powers Significant Genomic Research in Arab Populations | PACB Stock News - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand - Yahoo.co

Jul 24, 2025
pulisher
Jul 24, 2025

Publication spotlight: How Kinnex long-read RNA sequencing wins out over Illumina for transcript-level quantification - PacBio

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Pacific Biosciences of California Inc. stockExceptional earning trajectories - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Intrinsic Value Is Potentially 41% Above Its Share Price - 富途牛牛

Jul 23, 2025
pulisher
Jul 23, 2025

Why PacBio (PACB) Stock Is Up Today - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

QIAGEN’s New Sequencing Panels Boosts PacBio Expansion - StocksToTrade

Jul 23, 2025
pulisher
Jul 23, 2025

Pacific Biosciences: The Shift To Razor-Blade Economics Could Be A Game Changer - Seeking Alpha

Jul 23, 2025
pulisher
Jul 23, 2025

PacBio Joins 1000 Genomes Long Read Sequencing Project to Enhance Human Genomics Research - Nasdaq

Jul 23, 2025
pulisher
Jul 23, 2025

PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Is Pacific Biosciences of California Inc. a good long term investmentPhenomenal wealth increase - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

QIAGEN Expands NGS Portfolio with QIAseq xHYB Long Read Panels - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Pacific Biosciences of California Inc. stock priceRapid capital growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

PacBio (PACB) Collaborates with Qiagen for Enhanced Genomic Insi - GuruFocus

Jul 22, 2025
pulisher
Jul 22, 2025

QIAGEN launches long-read sequencing panels for complex genomic regions By Investing.com - Investing.com Canada

Jul 22, 2025
pulisher
Jul 22, 2025

PACB Stock Rally: Bullish Signs or Temporary Spike? - StocksToTrade

Jul 22, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-22 17:54:31 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

DNA Sequencing Leader PacBio Sets Q2 2025 Earnings Release Date: What Analysts Are Watching - Stock Titan

Jul 21, 2025
pulisher
Jul 17, 2025

Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know - Yahoo.co

Jul 17, 2025
pulisher
Jul 17, 2025

How long-read sequencing uncovers hitchhikers of the genomic galaxy in parasitic fungi - PacBio

Jul 17, 2025
pulisher
Jul 16, 2025

Pacific Biosciences Stock Jumps Amid Strategic Acquisitions - StocksToTrade

Jul 16, 2025
pulisher
Jul 16, 2025

Pacific Biosciences Sees Stock Uptick Following Strategic Moves - timothysykes.com

Jul 16, 2025
pulisher
Jul 11, 2025

Chromosome-level genome assembly with telomeric repeats at scaffold ends for Rhabdosargus sarba - Nature

Jul 11, 2025

Finanzdaten der Pacific Biosciences Of California Inc-Aktie (PACB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$292.27
price up icon 0.71%
medical_devices STE
$226.53
price down icon 1.71%
medical_devices PHG
$25.66
price down icon 1.91%
$89.53
price up icon 0.61%
$77.74
price up icon 0.17%
medical_devices EW
$78.49
price down icon 1.89%
Kapitalisierung:     |  Volumen (24h):